Related Experiment Video
Updated: Jun 17, 2025
A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries
Published on: December 27, 2016
Antibiofilm and Antivirulence Potentials of 3,2'-Dihydroxyflavone against Staphylococcus aureus
Inji Park1, Yong-Guy Kim1, Jin-Hyung Lee1
1School of Chemical Engineering, Yeungnam University, Gyeongsan 38541, Republic of Korea.
Abstract:
Staphylococcus aureus, particularly drug-resistant strains, poses significant challenges in healthcare due to its ability to form biofilms, which confer increased resistance to antibiotics and immune responses. Building on previous knowledge that several flavonoids exhibit antibiofilm activity, this study sought to identify a novel flavonoid capable of effectively inhibiting biofilm formation and virulence factor production in S. aureus strains including MRSA. Among the 19 flavonoid-like compounds tested, 3,2'-dihydroxyflavone (3,2'-DHF) was identified for the first time as inhibiting biofilm formation and virulence factors in S. aureus with an MIC 75 µg/mL. The antibiofilm activity was further confirmed by microscopic methods. Notably, 3,2'-DHF at 5 µg/mL was effective in inhibiting both mono- and polymicrobial biofilms involving S. aureus and Candida albicans, a common co-pathogen. 3,2'-DHF reduces hemolytic activity, slime production, and the expression of key virulence factors such as hemolysin gene hla and nuclease gene nuc1 in S. aureus. These findings highlight the potential of 3,2'-DHF as a novel antibiofilm and antivirulence agent against both bacterial and fungal biofilms, offering a promising alternative to traditional antibiotics in the treatment of biofilm-associated infections.
Insights
A novel compound, 3,2'-dihydroxyflavone (3,2'-DHF), effectively inhibits biofilm formation and virulence in drug-resistant Staphylococcus aureus. This discovery offers a promising alternative for treating challenging biofilm-associated infections.
Area of Science:
- Microbiology
- Drug Discovery
- Biochemistry
Background:
- Drug-resistant *Staphylococcus aureus* strains, particularly Methicillin-resistant *S. aureus* (MRSA), present significant healthcare challenges due to biofilm formation.
- Biofilms increase pathogen resistance to antibiotics and host immune responses.
- Previous research indicates that certain flavonoids possess antibiofilm properties.
Purpose of the Study:
- To identify a novel flavonoid compound with potent antibiofilm and anti-virulence activity against *S. aureus*.
- To evaluate the efficacy of identified compounds against biofilm formation and virulence factor production in *S. aureus*, including MRSA strains.
Main Methods:
- Screening of 19 flavonoid-like compounds for antibiofilm activity against *S. aureus*.
- Determination of Minimum Inhibitory Concentration (MIC) for effective compounds.
- Microscopic analysis to confirm antibiofilm effects.
- Assessment of inhibition against mono- and polymicrobial biofilms (including *Candida albicans*).
- Evaluation of virulence factor reduction, including hemolytic activity, slime production, and gene expression (*hla*, *nuc1*).
Main Results:
- 3,2 ahydroxyflavone (3,2 ahydroxyflavone) was identified as a novel inhibitor of *S. aureus* biofilm formation and virulence factors, with an MIC of 75 µg/mL.
- 3,2 ahydroxyflavone demonstrated efficacy at 5 µg/mL against both mono- and polymicrobial biofilms involving *S. aureus* and *Candida albicans*.
- The compound significantly reduced hemolytic activity, slime production, and the expression of key virulence genes (*hla* and *nuc1*) in *S. aureus*.
Conclusions:
- 3,2 ahydroxyflavone is a promising novel agent for combating *S. aureus* biofilm formation and associated virulence.
- This flavonoid shows potential as an antibiofilm and anti-virulence agent against polymicrobial infections.
- 3,2 ahydroxyflavone represents a potential alternative therapeutic strategy for biofilm-associated infections, including those caused by MRSA.
More Related Videos
06:36Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds
Published on: September 8, 2021
08:20Systematic Approach to Identify Novel Antimicrobial and Antibiofilm Molecules from Plants' Extracts and Fractions to Prevent Dental Caries
Published on: March 31, 2021
Related Concept Videos
01:18Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
01:27Combined Effects of Drugs: Synergism
Such synergistic combinations...